Earnings Releases·Oct 29, 2026, 7:18 AM ET

Baxter International Inc. — Third Quarter 2026 Earnings Summary

Worldwide sales reached $2.98 billion, up 5% year-over-year on both reported and organic bases, while U.S. GAAP net income turned positive at $298 million ($0.57/share) compared to a $51 million loss in Q3 2025; however, adjusted diluted EPS declined 16% to $0.58 due to a higher effective tax rate.
The company raised full-year 2026 guidance for reported sales growth (4%–5%), organic sales growth (3%–4%), and adjusted diluted EPS ($2.05–$2.15), reflecting strong performance across all global segments.
Strategic capital allocation included a $600 million cash tender offer to retire $864 million of debt, while free cash flow totaled $448 million for the quarter and $705 million year-to-date.
Management decreased the quarterly dividend to $0.01 per share and noted that significant indebtedness constrains future R&D and growth strategies, alongside ongoing risks from product quality issues and regulatory challenges.